SFM
HSTO

Soros Fund Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Soros Fund Management’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-98
Closed -$178K – 375
2014
Q2 		$178K Buy
+98
New +$131K ﹤0.01% 302

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Soros Fund Management's HSTO Position: Q3 2014 in Review

Soros Fund Management sold out of Histogen Inc. Common Stock (HSTO) in Q3 2014, closing a stake of 98 shares — an estimated $178K sold.

Soros Fund Management first reported a position in HSTO in Q2 2014 and held it in 1 quarter. The position peaked at $178K in Q2 2014. 34 funds tracked by Wall St. Rank hold HSTO as of Q3 2014.

  • Soros Fund Management reported no remaining Histogen Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • Soros Fund Management sold 98 Histogen Inc. Common Stock shares in Q3 2014, an estimated $178K.
  • Soros Fund Management first reported a position in Histogen Inc. Common Stock in Q2 2014 and held it in 1 quarter.
  • Soros Fund Management's Histogen Inc. Common Stock position peaked at $178K in Q2 2014.
  • 34 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2014.

Based on Soros Fund Management's 13F filing for Q3 2014, filed 14 Nov 2014.